Profile data is unavailable for this security.
About the company
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
- Revenue in USD (TTM)2.50bn
- Net income in USD-1.34bn
- Incorporated2018
- Employees12.80k
- LocationEnvista Holdings Corp200 S. Kraemer Blvd., Bldg. EBREA 92821United StatesUSA
- Phone+1 (714) 817-5418
- Fax+1 (302) 655-5049
- Websitehttps://envistaco.com/en
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LeMaitre Vascular Inc | 213.03m | 41.32m | 2.34bn | 614.00 | 57.18 | 7.08 | 45.97 | 11.00 | 1.82 | 1.82 | 9.41 | 14.73 | 0.5992 | 1.11 | 7.59 | 346,952.80 | 11.62 | 9.02 | 12.66 | 9.93 | 68.34 | 65.83 | 19.40 | 15.45 | 5.52 | -- | -- | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Enovis Corp | 2.00bn | -121.38m | 2.59bn | 6.55k | -- | 0.7787 | 17.73 | 1.30 | -2.21 | -2.17 | 36.43 | 59.61 | 0.4023 | 1.59 | 5.91 | 305,598.20 | -2.43 | -0.3569 | -2.66 | -0.41 | 56.96 | 48.19 | -6.03 | -1.06 | 1.12 | 0.9889 | 0.2876 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| UFP Technologies Inc | 461.85m | 54.21m | 2.65bn | 3.09k | 49.28 | 8.04 | 39.36 | 5.73 | 7.00 | 7.00 | 59.64 | 42.89 | 0.8896 | 4.18 | 6.15 | 149,320.40 | 10.44 | 9.69 | 12.00 | 10.95 | 28.31 | 26.33 | 11.74 | 10.14 | 1.43 | 13.44 | 0.3918 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Irhythm Technologies Inc | 560.03m | -150.66m | 2.71bn | 2.00k | -- | 37.70 | -- | 4.83 | -4.85 | -4.85 | 18.04 | 2.29 | 0.83 | 12.56 | 8.79 | 280,012.50 | -22.33 | -21.92 | -26.27 | -26.77 | 67.83 | 69.39 | -26.90 | -25.75 | 6.12 | -24.18 | 0.90 | -- | 19.90 | 27.32 | -6.24 | -- | 50.82 | -- |
| LivaNova PLC | 1.24bn | 23.68m | 2.80bn | 2.90k | 121.22 | 2.14 | 41.31 | 2.26 | 0.4259 | 0.4259 | 22.81 | 24.13 | 0.5119 | 2.47 | 6.42 | 428,185.90 | 0.9777 | -6.01 | 1.12 | -7.42 | 67.78 | 66.99 | 1.91 | -13.56 | 2.87 | 2.46 | 0.3234 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
| TransMedics Group Inc | 401.09m | 32.64m | 2.89bn | 584.00 | 91.58 | 13.75 | 57.21 | 7.19 | 0.9389 | 0.9389 | 11.60 | 6.25 | 0.5439 | 3.56 | 5.32 | 686,797.90 | 4.43 | -16.08 | 4.78 | -17.95 | 59.34 | 65.37 | 8.14 | -40.47 | 7.33 | -- | 0.7078 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| Quidelortho Corp | 2.83bn | -1.86bn | 2.94bn | 7.10k | -- | 0.925 | -- | 1.04 | -27.79 | -27.79 | 42.35 | 47.30 | 0.372 | 2.58 | 9.15 | 399,239.40 | -24.40 | 11.34 | -27.51 | 12.91 | 47.89 | 62.71 | -65.60 | 20.93 | 0.7929 | 0.7895 | 0.4469 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
| Inari Medical Inc | 574.50m | -78.58m | 3.01bn | 1.30k | -- | 6.91 | -- | 5.24 | -1.35 | -1.35 | 9.90 | 7.44 | 0.9221 | 1.59 | 7.46 | 441,921.50 | -12.61 | -0.5941 | -15.24 | -0.6696 | 86.82 | 89.06 | -13.68 | -0.6295 | 1.40 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
| Envista Holdings Corp | 2.50bn | -1.34bn | 3.51bn | 12.80k | -- | 1.14 | -- | 1.40 | -7.77 | -7.77 | 14.51 | 17.86 | 0.4106 | 4.21 | 6.19 | 195,570.30 | -21.93 | 1.94 | -25.27 | 2.34 | 54.20 | 57.65 | -53.42 | 5.29 | 1.77 | 3.13 | 0.3163 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| Neogen Corp | 912.20m | -23.53m | 3.52bn | 2.92k | -- | 1.12 | 37.32 | 3.86 | -0.1086 | -0.1086 | 4.21 | 14.47 | 0.2013 | 2.71 | 5.98 | 312,718.20 | -0.5193 | 1.38 | -0.5346 | 1.44 | 49.56 | 48.23 | -2.58 | 4.31 | 2.79 | 1.03 | 0.2215 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
| Guardant Health Inc | 692.26m | -512.41m | 3.53bn | 1.78k | -- | -- | -- | 5.11 | -4.24 | -4.24 | 5.70 | -0.488 | 0.415 | 3.68 | 7.81 | 389,126.50 | -30.72 | -22.26 | -35.19 | -24.59 | 60.31 | 64.62 | -74.02 | -97.07 | 5.85 | -8.04 | 1.06 | -- | 25.45 | 44.14 | 26.76 | -- | 0.2786 | -- |
| Axonics Inc | 431.90m | -5.66m | 3.60bn | 797.00 | -- | 5.42 | 527.59 | 8.33 | -0.108 | -0.108 | 8.52 | 13.00 | 0.602 | 1.07 | 7.74 | 541,909.70 | -0.7889 | -12.67 | -0.848 | -13.76 | 76.59 | 70.04 | -1.31 | -29.68 | 6.40 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
| DENTSPLY SIRONA Inc | 3.90bn | -413.00m | 3.62bn | 15.00k | -- | 1.43 | -- | 0.9283 | -2.07 | -2.07 | 18.91 | 12.53 | 0.5641 | 2.94 | 5.91 | 260,000.00 | -5.93 | -1.14 | -7.41 | -1.32 | 52.18 | 53.65 | -10.51 | -2.51 | 0.8444 | 3.21 | 0.471 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| ICU Medical Inc | 2.30bn | -70.79m | 4.32bn | 14.00k | -- | 2.12 | 27.53 | 1.87 | -2.92 | -2.92 | 94.90 | 83.43 | 0.5267 | 2.13 | 14.68 | 164,591.20 | -1.62 | 1.46 | -1.83 | 1.65 | 32.47 | 34.11 | -3.07 | 2.23 | 1.08 | 0.5555 | 0.4412 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Haemonetics Corporation | 1.33bn | 114.89m | 4.47bn | 3.66k | 39.16 | 4.94 | 20.50 | 3.35 | 2.23 | 2.23 | 25.92 | 17.70 | 0.5924 | 1.87 | 7.05 | 364,751.20 | 5.10 | 5.02 | 5.74 | 6.07 | 53.58 | 51.74 | 8.61 | 8.11 | 2.33 | 60.20 | 0.5747 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
| Integer Holdings Corp | 1.68bn | 114.44m | 4.59bn | 10.50k | 42.17 | 2.83 | 20.73 | 2.73 | 3.24 | 3.22 | 47.87 | 48.33 | 0.5594 | 4.93 | 5.14 | 160,023.80 | 3.81 | 3.28 | 4.10 | 3.53 | 27.06 | 26.94 | 6.81 | 6.40 | 2.09 | 4.11 | 0.4028 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
Data as of Nov 09 2024. Currency figures normalised to Envista Holdings Corp's reporting currency: US Dollar USD
57.63%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 17.02m | 9.90% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 15.46m | 8.99% |
| Atlanta Capital Management Co. LLCas of 30 Jun 2024 | 12.37m | 7.19% |
| Harris Associates LPas of 30 Jun 2024 | 10.78m | 6.27% |
| Ariel Investments LLCas of 30 Jun 2024 | 9.87m | 5.74% |
| American Century Investment Management, Inc.as of 30 Sep 2024 | 8.81m | 5.12% |
| Nuance Investments LLCas of 30 Sep 2024 | 7.35m | 4.27% |
| Gates Capital Management, Inc.as of 30 Jun 2024 | 6.87m | 3.99% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 5.33m | 3.10% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 5.24m | 3.05% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
